C

Clearside Biomedical
D

CLSD

0.80590
USD
-0.00
(-0.51%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
62,625,309
أصول ذات صلة
C
CRSP
0.050
(0.12%)
41.360 USD
C
CRVS
-0.05000
(-1.18%)
4.18000 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
N
NTLA
-0.04000
(-0.48%)
8.31000 USD
R
RGNX
-0.95500
(-9.35%)
9.26000 USD
S
SGMO
-0.02290
(-4.55%)
0.48010 USD
V
VCEL
0.175
(0.41%)
42.645 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.